Humacyte, Inc. (HUMA) closed the most recent trading day at $0.78, moving -2.32% from the previous trading session. This change lagged the S&P 500's 0.79% gain on the day. Meanwhile, the Dow ...

Humacyte, Inc. (HUMA) concluded the recent trading session at $0.62, signifying a -11.14% move from its prior day's close.

In the latest market close, Humacyte, Inc. (HUMA) reached $5.05, with a -1.94% movement compared to the previous day. The stock's change was less than the S&P 500's daily loss of 1.86%. Meanwhile, the ...

Humacyte said it will use the money to support sales of its recently FDA-approved product Symvess and prepare an application for FDA approval of its vessel in dialysis patients, among other things.

Humacyte’s fair value estimate has been reset from US$7.86 to US$2.05, marking a sharp recalibration of how analysts are framing the stock’s potential. Recent research highlights a split view, with ...

Humacyte Inc. Annual cash flow by MarketWatch. View HUMA net cash flow, operating cash flow, operating expenses and cash dividends.